A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/2006
11/08/2006	EP1718664A2 Modified human four helical bundle polypeptides and their uses
11/08/2006	EP1718568A2 Process for preparing water soluble diterpenes and their applications
11/08/2006	EP1718341A2 Articles comprising magnetic material and bioactive agents
11/08/2006	EP1718340A2 New effector conjugates, process for their production and their pharmaceutical use
11/08/2006	EP1718339A2 Modified human interferon polypeptides and their uses
11/08/2006	EP1718338A1 Compositions and methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells
11/08/2006	EP1718335A2 Drug conjugates
11/08/2006	EP1718330A2 Complexed polypeptide and adjuvant for improved vaccines
11/08/2006	EP1718283A2 Topical co-enzyme q10 formulations and methods of use
11/08/2006	EP1718277A1 Particles for inhalation rapid release properties
11/08/2006	EP1718276A2 Inhalant formulation containing sulfoalkylether cyclodextrin and corticosteroid prepared from a unit dose suspension
11/08/2006	EP1718273A2 Compositions comprising vitamins and/or derivatives thereof stabilised with olea europea extract and/or ionene polymers
11/08/2006	EP1718145A2 Conjugates for cancer therapy and diagnosis
11/08/2006	EP1669379A4 3,5-dimethyl-1-adamantyl-ammonium polymeric salts and the use thereof in the form of antiviral agents
11/08/2006	EP1653933B1 Dermal or transdermal therapeutic system comprising an ormocer with barrier effect on a cover foil
11/08/2006	EP1649286A4 Improved aminodextran compositions and conjugates and methods of making and using them
11/08/2006	EP1502020A4 Stackable low depth tray
11/08/2006	EP1465604A4 Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
11/08/2006	EP0759695B1 A method of inducing an immune response using vaccinia virus recombinants, expressing the gm-csf gene
11/08/2006	CN1859926A Polymer encapsulation of adenoviruses
11/08/2006	CN1859925A Polymer conjugates of cytokines, chemokines, growth factors, polypeptide hormones and antagonists thereof with preserved receptor-binding activity
11/08/2006	CN1859920A Probiotic storage and delivery
11/08/2006	CN1859919A Anti-coronavirus agent
11/08/2006	CN1859905A Method of controlling particle size of retinoic acid nanoparticles coated with polyvalent metal inorganic salt and nano particles obtained by the controlling method
11/08/2006	CN1858071A Synthetic process for water soluble sulfoalkyl ether-beta-cyclic dextrine
11/08/2006	CN1857736A Polyglycol modified antitumor compound and its preparing method
11/08/2006	CN1857735A Process of preparing excipient with colloid food material
11/08/2006	CN1857734A Phytoagglutinin modified lactic acid-hydroxacetic acid copolymer and its preparing method
11/08/2006	CN1857733A Preparing process of bioadhesive chitosan particle for embedding and transferring active medicine
11/08/2006	CN1857732A In vivo cross-linked pectin skeleton administration system containing calcium salt in great weight portions
11/08/2006	CN1857731A Preparing process of kappa-carrageenan for medicine capsule
11/08/2006	CN1857730A Degradable implated medicine release-controlling carrier with micropores and cavities and its preparing process
11/08/2006	CN1857729A Medicine composition containing neohouttuynin sodium and solutol HS15
11/08/2006	CN1857728A Nanometer magnetic polylactic acid-phenyl arsine glycollate microballoon and its use
11/08/2006	CN1857727A Animal skin penetrant
11/08/2006	CN1857725A Slow released compound antituberculotic preparation containing synergist
11/08/2006	CN1857724A Slow released preparation containing antituberculotic
11/08/2006	CN1857723A Slow released anticancer medicine preparation with both amrubicin and its synergist
11/08/2006	CN1857721A Pyridoxal phosphate internally cross-linked hematoglobin nanocapsule and its preparing method
11/08/2006	CN1857714A Slow released antituberculotic preparation
11/08/2006	CN1857702A Detoxicated girald daphne and its externally applied transdermal absorption preparation and preparing process
11/08/2006	CN1857675A Zedoary oil eye drop and its preparing method
11/08/2006	CN1857328A Moisture-proof coating method for Chinese medicine granule
11/08/2006	CN1857312A Pretreating liquid and freeze protecting liquid for cryopreservation of erythrocyte and their application
11/08/2006	CN1857307A Liquid medicine preparation and its preparing process and use
11/08/2006	CN1857267A Suppository for auxiliary treatment of cervical carcinoma and its preparing method
11/08/2006	CN1857266A Fleroxacin injection and its preparing method
11/08/2006	CN1857261A Aquogel type thiamazole plaster preparation
11/08/2006	CN1857236A Compound medicine release controlling film of chitosan, sodium alginate and gelatin and its preparing process
11/08/2006	CN1857235A Absorbable medical film
11/08/2006	CN1857233A Medicine composition soft capsule and its preparing process
11/08/2006	CN1857232A Biodegradable nano magnetic capsule loading medicine and its preparing process
11/08/2006	CN1857231A Preparing process of biodegradable capsule loading medicine and nano magnetic particle
11/08/2006	CN1857230A Cefadroxil preparation and its preparing process
11/08/2006	CN1857227A Supercritical fluid aided double circulation process for carrying medicine onto polymer microballoon
11/08/2006	CN1857226A Magnetic polylactic acid-phenylarsine glycolate nano microballoon and its preparing process
11/08/2006	CN1857224A Preparing process of nano c-FLIP antisense oligonucleotide particle
11/08/2006	CN1857222A Submicron docetaxel emulsion for intravenous injection and its preparing process
11/08/2006	CN1857221A Slow released anticancer medicien containing both platinum compound and its synergist
11/08/2006	CN1857220A Slow released antituberculotic preparation
11/08/2006	CN1857219A Slow released medicine prepn containing antituberculotic
11/08/2006	CN1857218A Slow released medicine containing antituberculotic
11/08/2006	CN1857217A Slow released anticancer injection containing estrogen receptor antagonist
11/08/2006	CN1857216A Slow released injection containing satraplatin and its synergist
11/08/2006	CN1857215A Slow released injection containing antimetabolite
11/08/2006	CN1857214A Slow released anticancer injection with both antimetabolite and cellular poison medicine
11/08/2006	CN1857213A Slow released anticancer injection with both antimetabolite and cellular poison medicine
11/08/2006	CN1857212A Slow released anticancer injection containing antimetabolite and cellular poison medicine
11/08/2006	CN1857211A Slow released injection containing Nolatrexed and its synergist
11/08/2006	CN1857210A Slow released anticancer medicine with both antimetabolite and its synergist
11/08/2006	CN1857209A Slow released anticancer injection containing antimetabolite
11/08/2006	CN1857208A Slow released anticancer injection with both antimetabolite and its synergist
11/08/2006	CN1857207A Slow released compound anticancer injection containing blood vessel inhibitor
11/08/2006	CN1857206A Slow released anticancer injection containing blood vessel inhibitor
11/08/2006	CN1857205A Slow released injection containing blood vessel inhibitor and its synergist
11/08/2006	CN1857204A Slow released anticancer medicine with both blood vessel inhibitor and its synergist
11/08/2006	CN1857203A Slow released compound anticancer injection containing blood vessel inhibitor
11/08/2006	CN1857202A Slow released anticancer injection with blood vessel inhibitor and cellular poison medicine
11/08/2006	CN1857201A Slow released anticancer injection with both blood vessel inhibitor and its synergist
11/08/2006	CN1283664C Erythropoietin conjugate
11/08/2006	CN1283658C Proline ester and preparation containing the same for percutaneous administration
11/08/2006	CN1283318C Medicinal preparation of slowly-released bioactive substance, its prepn. and application
11/08/2006	CN1283313C Use of alpha-helix apolipoprotein or HDL-related protein in preparing drugs for prevention and treatment of restenosis by local administration
11/08/2006	CN1283250C Stabilized formulations of 6-hydroxy-3-(4-[piperidin-1-yl) ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene and salts thereof
11/08/2006	CN1283243C Taxane class derivative based pharmaceutical compositions
11/08/2006	CN1283242C Freeze-dried pharmaceutical preparation
11/08/2006	CN1283237C Curcumin and phosphatide composite and its preparation method
11/08/2006	CN1283235C Clear and stable propofol composition
11/08/2006	CN1283232C Process for coating solid particles
11/08/2006	CN1283231C Orally disintegrating tablet and its preparation
11/08/2006	CN1283229C New self emulsifying drug delivery system
11/08/2006	CN1283215C Biodegradable vehicles and delivery systems of biologically active substances
11/07/2006	US7133725 Method and related composition employing nanostructures
11/07/2006	US7132511 Modified anti-EGFR antibodies with reduced immunogenicity
11/07/2006	US7132506 Peptide having osteogenetic activity and osteogenetic accelerator containing the same
11/07/2006	US7132452 Useful for threapy of pain/inflammation associated with infection caused by herpes virus, especially herpes simplex virus (HSV) and varicella-zoster virus (VZV)
11/07/2006	US7132412 Treatment of skin diseases using a pharmaceutical preparation in colloidal form
11/07/2006	US7132118 Superoxide dismutase-containing cucumber extract coated and/or microencapsulated in a fat-soluble agent based on a fatty substance can be used by the topical or oral route; antiallergens; sunscreen agents; foods; drugs; cosmetics
11/07/2006	US7132114 Blending wih starch, lubricant, wetting agent; compression
11/07/2006	US7132113 High speed disintegration; mixture of hydroxypropyl cellulose and starch

1 ... 801 802 803 804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 820 821 ... 1712